title: Angioedema, lymphoproliferative disorder and angiotensin-converting enzyme inhibitors: masking of diagnosis by corticosteroids.
abstract: Angioedema is a relatively common clinical disorder. Although most cases are idiopathic, the use of angiotensin-converting enzyme inhibitors is a well recognized cause of angioedema and a further rare but important diagnostic consideration is acquired C1 inhibitor deficiency. We discuss the diagnosis of C1 inhibitor deficiency in angioedema, with reference to a case in which the diagnosis was initially masked by the use of corticosteroids, which normalized the C1 inhibitor level.
authors: Division of Immunology and Allergy, Royal Adelaide Hospital, Adelaide, South Australia, Australia. pravin.hissaria@imvs.sa.gov.au
authors: P
authors: P
authors: Hissaria
authors: S-W
authors: SW
authors: Lim
authors: C-H
authors: CH
authors: Hui
authors: D
authors: D
authors: Gillis
authors: F
authors: F
authors: Kette
authors: W
authors: W
authors: Smith
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000368:Aged; D000799:Angioedema / Q000175:diagnosis* / Q000188:drug therapy; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000175:diagnosis* / Q000188:drug therapy
chemical_list: D000305:Adrenal Cortex Hormones; D000806:Angiotensin-Converting Enzyme Inhibitors